Oncology Support

Oncology Support

Cancer is a disease characterized by uncontrolled cell growth. It is a scary and oftentimes fatal diagnosis. Fortunately, with earlier detection and improvements in treatment, medicine has improved the outcomes for people with cancer. Some cancers that were once automatically fatal can now be treated successfully by oncologists.

The are also ways for people to help promote healthy cell division naturally. Two natural, nontoxic, nutrients shown to exert powerful benefits for improving cell division and the immune system are MK4 and vitamin D. Even the FDA agreed that these nutrients show promise for helping people with cancer when they awarded Orphan Drug Designations to NBI Pharmaceuticals for MK4 to potentially treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), hepatocellular carcinoma (HCC) and acute promyelocytic leukemia (APL). Additionally, the FDA awarded orphan drug designation status to the combination product MK4 plus vitamin D for the treatment of MDS.

NBI Pharmaceuticals was founded in 2010 by Drs. Neustadt and Pieczenik to work with the FDA's Office of Orphan Products Development (OOPD) to create safe, nontoxic products for treating "orphan diseases." An orphan disease is any disease that affects less than 200,000 patients in the United States. Through the Orphan Drug Act and NBI Pharmaceuticals, Drs. Neustadt and Pieczenik submitted more than 30 orphan drug designation applications and received 15 orphan drug designations for MK4, MK4 plus vitamin D, and other products to potentially treat rare and deadly diseases. They were told by the head of the orphan drug program at the time, Timothy Cote, MD, that no other company in the history of the orphan drug program had ever submitted so many applications in such a short amount of time or received so many designations. Most companies only submit one to two applications per year.

NBI has summarized the studies on MK4 and Vitamin D for oncology support, which you can review to educate yourself on whether these nutrients are right for.

Since MK4 and Vitamin D are natural products, they are available as dietary supplements to promote health. While they have not been approved by the FDA to diagnose, treat, cure or prevent diseases, the research is very clear that published basic science and clinical trials show that these powerful nutrients help promote healthy cells in people with both blood cancers and solid tumors.

Osteo-K Oncology Support Customer Videos
Cancer Video Update: 71-yr Old Vibrant and Alive 1.5 Years After Starting Osteo-K
Osteo-K Oncology Support Video
Cancer Video Update: 71-yr Old Vibrant and Alive 1.5 Years After Starting Osteo-K 70-yr Old Cancer Patient Talks About His Experiences with Osteo-K and AML
Osteo-K Oncology Support Video
59-yr Old Cancer Patient Talks About Her Experiences with Osteo-K and AML

MK4 has been shown to:

  1. Promote healthy cell division in cancer cell lines.1
  2. Directly kill cancer cells without harming healthy cells.2
  3. Increase cell proteins involved in killing cancer cells.3,4,5
  4. Decrease cell proteins involved in prolonging the lives of cancer cells.6,7
  5. Slow or stop cancer cell growth.8

These studies were all in vitro studies, meaning they were done in a laboratory. More important than any laboratory data are human studies. After all, humans are not test tubes and human physiology is much more complicated than what can be created in a lab. And there are multiple human studies (clinical trials and case reports) and the power of MK4 by itself and with Vitamin D that clearly demonstrate the ability of these life-saving nutrients to promote health in patients with cancer.

Learn More

Watch the videos of a 59-year old woman and 70-year old man with AML who were both told they were going to die, but who started taking Osteo-K and they improved.

MK4 Research Summary Tables
Blood Cancers
About Myelodysplastic Syndrome
About Acute Myeloid Leukemia
About Hepatitis C